Study summary · research use only
Teriparatide in Fracture Non-Unions
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This human case series examined the use of teriparatide in the management of fracture nonunions. Four patients received teriparatide after open fixation of traumatic lower-limb fractures for management of nonunion. The abstract reports that teriparatide administration resulted in adequate bone callus formation at the nonunion site in all patients, with clinical and radiographic evidence of union. The authors state that the therapeutic benefit of teriparatide in delayed or nonunions remains unclear, and suggest it may induce an angiogenic response that counteracts factors associated with nonunion development. The study is described as a Level IV therapeutic case series.
Abstract
The use of teriparatide in the management of fracture disorders is poorly documented. This study aims to show that teriparatide administration may improve the healing process in patients with nonunions after open fixation of traumatic fractures of the lower limb. Four patients received Teriparatide for management of non-unions after open fixation of traumatic fractures of the lower limb. Teriparatide administration resulted in adequate bone callus over the site of nonunion in all the patients, and clinical and radiographic evidence of sound union. The efficacy of teriparatide in delayed or non unions is still unclear. It may induce an angiogenetic response which counteracts the features responsible for development of non-union. Level IV, therapeutic case series.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.